Dec 01, 2014 7:00am EST CollPlant Launched a Clinical Trial With Vergenix®FG; A Gel Based on a Human Collagen for the Treatment of Chronic Wounds
Jun 23, 2014 9:16am EDT CollPlant Holds Intellectual Property Rights in USA - One of the Largest Target Markets for the Company's Products: US Patent Office Approves Patent for Company's Collagen Production Techniques
Jun 16, 2014 11:53am EDT CollPlant Takes a Step Closer to Commercializing its Vergenix Flowable Gel Product for Treating Wounds: Receives Approval to Carry Out Clinical Trial